AI drug discovery hype check: without a simulator, no patent-grabbing windfall
kuza55 · x · 2026-10-08
In a debate over whether early access to frontier models could let someone scoop up drug patents ahead of bio labs, kuza55 pushes back: a perfect drug discovery system would indeed make its owner rich, but we have nothing close to a biological simulator, so the premise doesn't hold. A pointed argument about the limits of AI for Science.
Related event: Skeptics Push Back on AI Drug Patent Gold Rush(2 posts)→
More from AGI Musings
- Agents Expose Legacy Software as 'Workflow Theater': Is TurboTax Doomed in Months? — signulll · 2026-10-08
- Singularity creator: people arguing LLMs might be conscious don't understand how they work — dansitu · 2026-10-08
- MIT's Concourse program shows how humanities training shapes responsible AI leadership — nordicinst · 2026-10-08
- Scott Aaronson's 'The Mathocalypse': math education and research in the age of capable AI — TMWNN · 2026-10-08
- Ex-OpenAI VP Brundage: outsiders discount industry insiders' views more than expected — Miles_Brundage · 2026-10-08
- Reply to math doomers: every AI hype forecast for software failed, math will be fine — gerardsans · 2026-10-08